But in a cruel paradox, people like Mr. Carter — who has been diagnosed with a brain tumor and epilepsy — find it difficult to obtain the drug in their country. Bureaucracy and regulation, uninformed physicians, limited supply and high costs make what in some cases could be a lifesaving drug nearly impossible to obtain.
Dr. Bastian Seidel, president of the Royal Australian College of General Practitioners, called the country’s distribution system “fragmented” and “not transparent.”
“We don’t have a consistent, regulatory framework that is either efficient or timely,” he said, “and this is what makes it so frustrating for medical practitioners and for patients who are clearly in need of medical treatment.”
The drug, which he takes orally as an oil and…